Interestingly, in MCF-7 breast cancer cells, LEP has been demonstrated to be able to sustain, in a dose-dependent manner, the cancer cell immortalization by upregulating the expression of Human Telomerase Reverse Transcriptase (hTERT) via STAT3 dimerization [55]. The gene discussed is STAT3; the disease is breast carcinoma.